Treating prolactinomas with dopamine agonists: always worth the gamble?

Sean Noronha, Victoria Stokes, Niki Karavitaki, Ashley Grossman
  • Endocrine, September 2015, Springer Science + Business Media
  • DOI: 10.1007/s12020-015-0727-2

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Niki Karavitaki